Whales with a lot of money to spend have taken a noticeably bullish stance on Moderna.

Looking at options history for Moderna (NASDAQ:MRNA) we detected 26 trades.

If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 38% with bearish.

From the overall spotted trades, 4 are puts, for a total amount of $161,480 and 22, calls, for a total amount of $1,274,892.

Predicted Price Range

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $25.0 to $75.0 for Moderna during the past quarter.

Insights into Volume & Open Interest

In terms of liquidity and interest, the mean open interest for Moderna options trades today is 2229.07 with a total volume of 3,825.00.

In the following chart, we are able to follow the development of volume and open interest of call and put options for Moderna's big money trades within a strike price range of $25.0 to $75.0 over the last 30 days.

Moderna Call and Put Volume: 30-Day Overview

Noteworthy Options Activity:

Symbol	PUT/CALL	Trade Type	Sentiment	Exp. Date	Ask	Bid	Price	Strike Price	Total Trade Price	Open Interest	Volume
MRNA	CALL	TRADE	BULLISH	12/15/28	$26.45	$25.55	$26.4	$25.00	$261.3K	183	442
MRNA	CALL	TRADE	BULLISH	12/15/28	$26.1	$25.2	$26.05	$25.00	$257.8K	183	342
MRNA	CALL	SWEEP	BEARISH	02/20/26	$3.5	$3.35	$3.5	$42.00	$147.8K	377	503
MRNA	PUT	SWEEP	BULLISH	02/20/26	$3.25	$3.2	$3.2	$42.00	$72.6K	378	228
MRNA	CALL	TRADE	BEARISH	05/15/26	$15.6	$13.85	$13.85	$30.00	$62.3K	130	46

About Moderna

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

In light of the recent options history for Moderna, it's now appropriate to focus on the company itself. We aim to explore its current performance.

Moderna's Current Market Status

• Trading volume stands at 4,254,325, with MRNA's price down by -1.24%, positioned at $43.52.
• RSI indicators show the stock to be may be approaching overbought.
• Earnings announcement expected in 11 days.

Professional Analyst Ratings for Moderna

A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $34.0.

• In a cautious move, an analyst from UBS downgraded its rating to Neutral, setting a price target of $34.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.